-
Benzinga's Bulls & Bears Of The Week: Altria, DowDupont, Oracle, Roku And More
Sunday, March 25, 2018 - 5:26pm | 773Read More...Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included top mining stocks and a Detroit automaker. Bearish calls featured biotech stocks and a key cloud player. Rising concerns about a trade war, another interest rate increase and a social...
-
Novavax CEO To Jim Cramer: 'We Are In For An Exciting Year'
Wednesday, January 13, 2016 - 11:11am | 209Read More...Novavax, Inc. (NASDAQ: NVAX) CEO Stanley Erck was a guest on Jim Cramer's "Mad Money" segment on Tuesday. Novavax is a clinical stage-vaccine company that targets known and newly emerging diseases. Its stock has lost around 20 percent since the start of 2016 more than 50 percent...
-
Earnings Expectations For The Week Of March 10: The Season Winds Down
Sunday, March 9, 2014 - 6:30pm | 899Read More...As the earnings season winds down, some the most anticipated quarterly reports this week. Most notably, reports will come from alternative energy companies FuelCell Energy (NASDAQ: FCEL) and Plug Power (NASDAQ: PLUG), retailers American Eagle Outfitters (NYSE: AEO) and Dollar General (NYSE: DG),...
-
Market Wrap For December 16: Dow Posts Triple Point Gain Ahead of Fed Meeting
Monday, December 16, 2013 - 5:55pm | 2347Read More...U.S stocks started off the week on a positive note with triple digit point gains for the Dow following one of the worst weeks in recent memory. Tuesday is an important day for the markets as the Fed begins its policy meeting which will last until Wednesday. After weeks of anticipating when (or...
-
Wedbush Initiates Coverage Of Novavax With Outperform Rating And $6 Price Target
Tuesday, March 15, 2011 - 9:20am | 161Read More...In a report published by Wedbush, it is initiating coverage of Novavax (NASDAQ: NVAX) with an Outperform rating and $6 price target. Wedbush said that Novavax was recently awarded a $97 million (potentially $179 with all options) BARDA contract to fund manufacturing capacity and clinical...
-
Novavax Awarded BARDA Contract, Increasing Target to $4
Tuesday, March 1, 2011 - 8:30am | 134Read More...According to Piper Jaffray, Novavax (NASDAQ: NVAX) has been awarded the BARDA contract, and is increasing its target to $4. Piper Jaffray reported that, after the close, the Department of Health and Human Services (HHS) awarded the much anticipated new flu vaccine contract to 2 companies including...
-
Piper Jaffray Raises PT On Novavax To $4
Tuesday, March 1, 2011 - 7:45am | 27Read More...Piper Jaffray has raised the price target on Novavax, Inc. (NASDAQ: NVAX) from $3 to $4 and maintains its Overweight rating.
-
How Hysteria Kills The Market (NVAX)
Wednesday, January 26, 2011 - 1:30pm | 643Read More...Asteroids. Y2K. The swine flu. Mad Cow disease. Killer wasps and killer Wi-Fi. What do these things have in common? They're all part of a graph designed by Information is Beautiful. Dubbed Mountains Out of Molehills, the graph is an interesting (and interactive) look at the world's greatest fears...
